Mercer Global Advisors
ABCL icon

Mercer Global Advisors’s AbCellera Biologics ABCL Stock Holding History

Mercer Global Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67K Buy
+1,105
New +$5.4K ﹤0.01% 5187

Other funds holding ABCL

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Mercer Global Advisors's ABCL Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 1,105 shares worth $8.67K. The stake represents ﹤0.01% of the portfolio and ranks #5187 among its holdings.

113 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Mercer Global Advisors held 1,105 shares of AbCellera Biologics worth $8.67K as of Q2 2026.
  • AbCellera Biologics was a new Mercer Global Advisors position in Q2 2026.
  • AbCellera Biologics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5187 holding.
  • 113 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.